Which clot-dissolving drug is best?
D002986:Clinical Trials as Topic; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D009316:National Institutes of Health (U.S.); D010361:Patients; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014481:United States
D013300:Streptokinase; D010959:Tissue Plasminogen Activator